Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another
Enlazado como:
Extracto
Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another
No longer available (Autolink)
Ver el contenido completo de este documento
Afectaciones
CONSIDERA CASO
- Cambridge Antibody Technology v Abbott Biotechnology Ltd and another
- Halliburton Energy Services Inc. v Smith International (North Sea) Ltd
- Menashe Business Mercantile Ltd and Another v William Hill Organisation Ltd
[ver más]
CONSIDERA
- Patents Act 1949
- Registered Designs Act 1949
- Astellas Pharma Inc. v Comptroller General of Patents
[ver más]
CITA
- Yeda Research and Development Company Ltd v Comptroller General of Patents
- Daiichi Sankyo Company Ltd v Comptroller General of Patents
- Cambridge Antibody Technology v Abbott Biotechnology Ltd and another
[ver más]
CONSIDERADA por
- Teva Pharma BV and Another v Amgen, Inc. and Another
- University of Queensland and Another v Comptroller-General of Patents, Designs and Trade Marks
- IPCom GmbH & Company KG v HTC Europe Company Ltd and Others Nokia Corporation (Opponent to Amendment Application)
[ver más]
CITADA NEUTRALMENTE por
- Resolution Chemicals Ltd v H. Lundbeck A/S
- Teva UK Ltd Accord Healthcare Ltd Lupin Ltd and Lupin Europe Ltd Generics (UK) Ltd Trading as Mylan v Gilead Sciences Inc.
REFERIDA por
- Sandoz Ltd and Another v G.d. Searle LLC and Another
- Teva UK Ltd and Another v Astrazeneca AB
- Eli Lilly and Company v Human Genome Sciences Inc.
[ver más]
AFIRMADA por
SEGUIDA por
REPORTED OPINION OF por
Documentos citados
- Operation Dismantle Inc. et al. v. Canada et al., (1985) 59 N.R. 1 (SCC)
- Vector Corporation v Glatt Air Techniques Inc.
- Medeva BV v The Comptroller General of Patents
- Windsurfing International Inc. v Tabur Marine (Great Britain) Ltd
- Menashe Business Mercantile Ltd and Another v William Hill Organisation Ltd